MLKL and melanoma: In another study, pretreatment with BAY 87-2243, a specific inhibitor of mitochondria complex-I, triggered ROS generation, mitochondrial dysfunction and mitophagy, following RIPK3/MLKL activation and induction of necroptosis in BRAFV600E melanoma cells.